AstraZeneca: Dr. Pelin Incesu’s Leadership Beyond Vaccines, Towards Gender Equality and Sustainability
In the aftermath of the COVID-19 pandemic, AstraZeneca garnered global recognition for its pivotal role in developing one of the earliest vaccines against the devastating virus. However, the pharmaceutical giant extends its impact far beyond vaccine development. With a commitment to innovation, sustainability, and leadership across various therapeutic areas, including oncology and chronic diseases, AstraZeneca stands as a pioneer in transforming lives.
Dr. Pelin Incesu, Area Vice President for the Middle East and Africa at AstraZeneca, attributes the company’s success to clear convictions and a robust moral compass. As a female leader within the organization, she emphasizes gender parity as a key indicator of AstraZeneca’s commitment to positive change. Dr. Incesu, a medical doctor and psychiatrist, is passionate about mentoring and empowering female leaders, contributing to the company’s objective of achieving gender parity by 2025.
Beyond gender equality, Dr. Incesu believes in the importance of public-private partnerships to address broader healthcare challenges. AstraZeneca aims to be the partner of choice for governments and organizations, collaborating to find innovative solutions. Notable partnerships include initiatives with the Abu Dhabi Department of Health and G42 Healthcare in the UAE, as well as research and development collaborations with the Kingdom of Saudi Arabia.
Reflecting on AstraZeneca’s role during the COVID-19 crisis, Dr. Incesu underscores the necessity of strong collaboration to save lives. The company accelerated vaccine development and distributed over three billion doses globally, emphasizing the significance of partnerships in the healthcare ecosystem.
Sustainability is a pivotal priority for AstraZeneca, with a commitment to achieving net zero carbon emissions by 2045. Dr. Incesu sees climate change as a public health crisis and emphasizes the company’s responsibility to address it. AstraZeneca actively participated in COP 27 in Egypt, contributed to the launch of the Sustainable Markets Initiative, and focuses on decarbonizing health systems and patient care pathways, incorporating digitalization and AI.
As AstraZeneca looks forward to participating in COP 28 in the UAE, Dr. Incesu reaffirms the company’s dedication to creating a meaningful impact in healthcare and sustainability.